-
Signature
-
/s/ Leah Webb, Attorney-in-Fact for David A. Morken
-
Stock symbol
-
BAND
-
Transactions as of
-
Aug 28, 2025
-
Transactions value $
-
-$78,805
-
Form type
-
4
-
Date filed
-
9/2/2025, 04:34 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Morken David A. |
Chairman & CEO, Director |
C/O BANDWIDTH INC., 2230 BANDMATE WAY, RALEIGH |
/s/ Leah Webb, Attorney-in-Fact for David A. Morken |
2025-09-02 |
0001721962 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BAND |
Class A Common Stock |
Options Exercise |
$0 |
+4.24K |
+60.83% |
$0.00 |
11.2K |
Aug 28, 2025 |
Direct |
|
| transaction |
BAND |
Class A Common Stock |
Options Exercise |
$0 |
+7.73K |
+69% |
$0.00 |
18.9K |
Aug 28, 2025 |
Direct |
|
| transaction |
BAND |
Class A Common Stock |
Sale |
-$78.8K |
-5.22K |
-27.6% |
$15.09 |
13.7K |
Aug 29, 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BAND |
Restricted Stock Units |
Options Exercise |
$0 |
-4.24K |
-50% |
$0.00 |
4.24K |
Aug 28, 2025 |
Class A Common Stock |
4.24K |
|
Direct |
F3, F4 |
| transaction |
BAND |
Restricted Stock Units |
Options Exercise |
$0 |
-7.73K |
-16.67% |
$0.00 |
38.6K |
Aug 28, 2025 |
Class A Common Stock |
7.73K |
|
Direct |
F3, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: